Strategic Partnerships Blackrock Neurotech has a track record of high-profile collaborations and partnerships with both emerging and established players in the neuroscience and BCI space, including recent alliances with Cognixion, Phantom Neuro, Noldus, and others. Sales opportunities lie in structured co-development, integration, and co-marketing arrangements with research institutions, device manufacturers, and software providers seeking advanced neural interfaces.

FDA Breakthrough With MoveAgain receiving FDA Breakthrough Designation and the company positioned as a leading BCI innovator, there is a compelling case for hospitals, research hospitals, and clinics to explore early adoption, clinical trials support, and reimbursement-ready deployments. Target opportunity: identify centers of excellence and patient advocacy groups for funding and regulatory navigation services.

Scaleable Platform The company’s long-tested, high-performance implantable BCI and microelectrode arrays indicate a scalable platform suitable for multiple neurological conditions and applications. Sales focus can target system-wide deployments in university labs and medical centers seeking durable, high-channel-count BCIs, along with training, maintenance, and data analytics services.

Global Impact With over 500 global institutional partners and a diverse patient remit including ALS, Alzheimer’s, Parkinson’s, epilepsy, and paralysis, there is broad market potential across neurology and neurorehabilitation segments. Opportunities exist for regional partnerships, grant-supported deployments, and multinational clinical programs that require standardized integration and regulatory alignment.

Financial Power Significant funding and high revenue range position Blackrock Neurotech as a well-resourced vendor able to support large-scale deployments, long-term service contracts, and accelerated R&D collaboration. Leverage financial backing to offer flexible pricing models, pilot programs, and rapid-scale onboarding for high-value research institutions and hospitals.